Zacks Investment Research upgraded shares of SeaSpine Holdings Corporation (NASDAQ:SPNE) from a hold rating to a buy rating in a research report report published on Wednesday morning. They currently have $12.00 target price on the medical equipment provider’s stock.

According to Zacks, “SeaSpine Holdings Corporation is a medical technology company which focused on the design, development and commercialization of surgical solutions for the treatment of spinal disorders. The company also offers orthobiologics and spinal fusion hardware solutions. SeaSpine Holdings Corporation is headquartered in Vista, California. “

Several other equities research analysts have also recently commented on SPNE. HC Wainwright set a $15.00 target price on shares of SeaSpine Holdings Corporation and gave the stock a buy rating in a research report on Monday, August 7th. Piper Jaffray Companies reaffirmed a buy rating and issued a $22.00 target price on shares of SeaSpine Holdings Corporation in a research report on Sunday, August 20th. Finally, BTIG Research reaffirmed a buy rating on shares of SeaSpine Holdings Corporation in a research report on Monday. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. SeaSpine Holdings Corporation currently has a consensus rating of Buy and a consensus target price of $16.33.

SeaSpine Holdings Corporation (NASDAQ SPNE) traded up $0.06 during midday trading on Wednesday, hitting $10.42. 49,457 shares of the company’s stock were exchanged, compared to its average volume of 27,429. SeaSpine Holdings Corporation has a 12-month low of $6.31 and a 12-month high of $13.46.

ILLEGAL ACTIVITY NOTICE: “SeaSpine Holdings Corporation (SPNE) Upgraded to Buy at Zacks Investment Research” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.dailypolitical.com/2017/11/09/seaspine-holdings-corporation-spne-upgraded-to-buy-at-zacks-investment-research.html.

Several large investors have recently bought and sold shares of the company. Schwab Charles Investment Management Inc. lifted its position in shares of SeaSpine Holdings Corporation by 1.0% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 18,707 shares of the medical equipment provider’s stock worth $216,000 after purchasing an additional 190 shares during the period. Northern Trust Corp lifted its position in shares of SeaSpine Holdings Corporation by 2.3% in the 2nd quarter. Northern Trust Corp now owns 24,869 shares of the medical equipment provider’s stock worth $286,000 after purchasing an additional 559 shares during the period. UBS Asset Management Americas Inc. lifted its position in shares of SeaSpine Holdings Corporation by 1.7% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 134,891 shares of the medical equipment provider’s stock worth $1,554,000 after purchasing an additional 2,209 shares during the period. FNY Partners Fund LP lifted its position in shares of SeaSpine Holdings Corporation by 7.6% in the 2nd quarter. FNY Partners Fund LP now owns 41,000 shares of the medical equipment provider’s stock worth $472,000 after purchasing an additional 2,902 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its position in shares of SeaSpine Holdings Corporation by 2.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 249,499 shares of the medical equipment provider’s stock worth $2,874,000 after purchasing an additional 5,655 shares during the period. 39.36% of the stock is owned by hedge funds and other institutional investors.

About SeaSpine Holdings Corporation

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.

Receive News & Ratings for SeaSpine Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.